Nightingale Health Oyj
F:7XE

Watchlist Manager
Nightingale Health Oyj Logo
Nightingale Health Oyj
F:7XE
Watchlist
Price: 1.67 EUR Market Closed
Updated: Jun 1, 2024

Gross Margin
Nightingale Health Oyj

85.9%
Current
76%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
85.9%
=
Gross Profit
3.6m
/
Revenue
4.2m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
FI
Nightingale Health Oyj
F:7XE
100.8m EUR
86%
US
Cigna Corp
NYSE:CI
97.9B USD
12%
US
Cigna Group
XMUN:CGN
87.3B EUR
12%
US
CVS Health Corp
NYSE:CVS
74.6B USD
15%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.5B EUR
23%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.4B USD
28%
US
Quest Diagnostics Inc
NYSE:DGX
15.8B USD
33%
US
DaVita Inc
NYSE:DVA
12.9B USD
32%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.5B EUR
25%
DE
Fresenius Medical Care AG
XMUN:FME
11.4B EUR
25%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
Nightingale Health Oyj
F:7XE
Country FI
Market Cap 100.8m EUR
Gross Margin
86%
Cigna Corp
NYSE:CI
Country US
Market Cap 97.9B USD
Gross Margin
12%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 87.3B EUR
Gross Margin
12%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 74.6B USD
Gross Margin
15%
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 16.5B EUR
Gross Margin
23%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 16.4B USD
Gross Margin
28%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 15.8B USD
Gross Margin
33%
DaVita Inc
NYSE:DVA
Country US
Market Cap 12.9B USD
Gross Margin
32%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 11.5B EUR
Gross Margin
25%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 11.4B EUR
Gross Margin
25%
Oak Street Health Inc
NYSE:OSH
Country US
Market Cap 9.5B USD
Gross Margin
4%

Profitability Report

View the profitability report to see the full profitability analysis for Nightingale Health Oyj.

Full Profitability Report

See Also

Summary
7XE intrinsic value, competitors valuation, and company profile.
DCF Valuation
7XE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
7XE stock valuation using valuation multiples.
Wall Street Estimates
7XE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
7XE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
85.9%
=
Gross Profit
3.6m
/
Revenue
4.2m
What is the Gross Margin of Nightingale Health Oyj?

Based on Nightingale Health Oyj's most recent financial statements, the company has Gross Margin of 85.9%.

ALPHA SPREAD
Join more than 142,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.